GW Sledge

Progress in chemotherapy for metastatic breast cancer.

GW Sledge, Antman Kh · PubMed · 1992 · 70 citations

Medicine, Oncology, Pharmacology +12

Abstract S5-5: Trastuzumab plus adjuvant chemotherapy for HER2-positive breast cancer: Final planned joint analysis of overall survival (OS) from NSABP B-31 and NCCTG N9831

Edward H. Romond, VJ Suman, J-H Jeong et al. · Cancer Research · 2012 · 47 citations

Medicine, Oncology, Pharmacology +17

Abstract S1-1: Final Analysis of NCIC CTG MA.27: A Randomized Phase III Trial of Exemestane Versus Anastrozole in Postmenopausal Women with Hormone Receptor Positive Primary Breast Cancer

PE Goss, JN Ingle, J-AW Chapman et al. · Cancer Research · 2010 · 24 citations

Medicine, Oncology, Pharmacology +16

Abstract GS6-03: Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II-III breast cancer

JA Sparano, Anne O’Neill, Katherine Alpaugh et al. · Cancer Research · 2018 · 17 citations

Medicine, Oncology, Breast Oncology +16

Abstract S1-07: Prognostic value of tumor-infiltrating lymphocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Sylvia Adams, Ronan Gray, Sandra Demaria et al. · Cancer Research · 2013 · 15 citations

Medicine, Immunology, Oncology +17